The cadherin-catenin complex is important for mediating homotypic, calcium-dependent cell-cell interactions in diverse tissue types. Although proteins of this complex have been identified, little is known about their interactions. Using a genetic assay in yeast and an in vitro protein-binding assay, we demonstrate that 13-catenin is the linker protein between E-cadherin and c-catenin and that E-cadherin does not bind directly to a-catenin. We show that a 25-amino acid sequence in the cytoplasmic domain of E-cadherin and the amino-terminal domain of a-catenin are independent binding sites for 8-catenin. In addition to 13-catenin and plakoglobin, another member of the armadillo family, p120 binds to E-cadherin. However, unlike 13-catenin, p120
regulatory mechanisms involved in the assembly and function of the cadherin-catenin complex.
The cadherin superfamily comprises glycoproteins responsible for calcium-dependent, homotypic cell interactions (1) . Ecadherin is generally expressed in epithelial tissues and has been shown to regulate cell-cell adhesion (2) , cell migration (3), morphogenesis (4) , and the establishment of membrane polarity (5) .
Homotypic interactions between extracellular domains of cadherins are necessary but not sufficient for cell-cell adhesion (2) . Linkage of the cadherin cytoplasmic domain to three cytosolic proteins, named a-catenin, ,B-catenin, and plakoglobin (y-catenin), is required (6) (7) (8) . Although a-catenin, 3-catenin, and plakoglobin can be coimmunoprecipitated in a complex with E-cadherin (1, 7) , the binding order of proteinprotein interactions has not been resolved. Insight into this problem is important for understanding functions of the cadherin-catenin complex and the regulation of cadherincatenin complex assembly. Here, we define the binding order of protein-protein interactions in the cadherin-catenin complex using genetic and biochemical approaches.
MATERIALS AND METHODS
Strain and Microbiological Techniques. All cloning procedures and bacterial transformation were performed by standard procedures outlined by Sambrook et at (9) . Yeast strain Y190 (MATa gal4 gal80 his3-200 trpl-901 ade2-101 ura3-52
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. leu2-3,112 lys2-801 URA3::GAL --lacZ LYS2::GAL -> HIS3) was used in the two-hybrid analysis and was provided by Stephen J. Elledge (Baylor College of Medicine, Houston). Yeast transformations were performed by the lithium acetate/ polyethylene glycol method (10) .
A 499-bp DNA fragment corresponding to the coding sequence of the cytoplasmic domain of canine E-cadherin (E-cadCD) was generated by PCR with synthetic oligonucleotides 5'-GGATCCGGAGGAGAAGGGTGGTCAAAGAG-CC-3' and 5'-GGAAGGCCGTCGACTCATCTTCATTTG-TCTCAAGTCCCCTAG-3'. This fragment was cloned into the BamHI and Sal I sites of pAS1CYH2 (provided by Stephen J. Elledge) to generate a GAL4 DNA-binding domain (GAL4bd)-E-cadCD fusion protein. The same PCR-amplified fragment was cloned into the Sal I and Xho I sites of pACT2 (provided by Stephen J. Elledge) to generate a GAL4 DNA transcriptional-activation domain (GAL4ad)-E-cadCD fusion protein; a similar construct [GAL4ad-E-cad(-25)] but with a 25-amino acid deletion from amino acids 815 to 839 E-cadCD was also made by using the construct pUMAC25 (11) . Fulllength mouse ,B-catenin coding sequence, provided by Rolf Kemler, was cloned into Nde I and Xho I sites of pACT2 to generate a GAL4ad-13-catenin fusion protein (GAL4ad-13-cat). Full-length mouse a-catenin coding sequence, provided by Rolf Kemler, was fused in the correct open reading frame with pAS1CYH2 and pACT2 vectors to generate plasmids expressing GAL4bd-a-catenin and GAL4ad-a-catenin fusion proteins, respectively. In addition, a-catenin coding sequence corresponding to amino acids 1-606 was cloned in frame into GAL4bd vector to generate GAL4bd-a-catenin(N) fusion protein, and the coding sequence corresponding to the C-terminal 300 amino acids of a-catenin was fused in frame to generate GAL4bd-a-catenin(C) fusion protein. All plasmid constructs were confirmed by restriction analysis and DNA nucleotide sequencing. The glutathione S-transferase (GST)-E-cadCD fusion protein was previously constructed and characterized (12) . Recombinant a-catenin was generated by cloning fulllength a-catenin cDNA into the histidine-tag expression vector, pQE60 (Diagen, Chatsworth, CA). The resulting Cterminally tagged a-catenin was purified according to the manufacturer's instructions (Diagen).
Two-Hybrid Analysis. Yeast strain Y190 was transformed with 1 ,g of each transforming DNA. Transformants were selected for growth on SC medium (Bio 101) lacking tryptophan and leucine (SC-Trp-Leu) and then was restreaked Abbreviations: GST, glutathione S-transferase; X-Gal, 5-bromo-4-chloro-3-indolyl B3-D-galactoside; SV40 (15) . Antibodies were detected by using 1251-labeled protein A or 1251-labeled goat anti-mouse IgG (Amersham), visualized by autoradiography, and quantified by using a phosphor imager (Fujix BAS 2000, Fuji). For in vitro binding assays with histidine-tagged a-catenin, 2.5 x 106 MDCK cells were lysed in 250 ,ul of MEBC buffer, and the soluble fraction was precleared by using 20 ,A of nickel-Sepharose bound to Escherichia coli extract at 4°C for 1 hr in the presence of 10 mM imidazole. The supernatant was incubated with 20 ,ul of nickel-Sepharose saturated with histidine-tagged a-catenin as described above. To remove unbound protein, the pellet was extensively washed with MEBC buffer containing 10 mM imidazole. Proteins were eluted with 20 ,lI of 100 mM EDTA and were heated in 2x SDS sample buffer at 37°C for 10 min, separated in SDS/7.5% PAGE gels, and processed for immunoblotting as above.
Filtration of Cell Lysates by Fast Protein Liquid Chromotography (FPLC). MEBC cell extracts were cleared by centrifugation at 100,000 x g and then filtered through a 0.22-,um filter (Millipore) before separation by FPLC (Pharmacia) on Superose 6 equilibrated in MEBC buffer containing 10 mM dithiothreitol and 0.1 mM Pefabloc. Fractions (0.5 ml) were collected; 400 gl of each fraction was used in the binding assay, and the remainder was separated in SDS/7.5% PAGE gels, and processed for immunoblotting as above.
RESULTS AND DISCUSSION
Determining the Hierarchy of Molecular Interactions in the Cadherin-Catenin Complex by Using the Yeast Two-Hybrid System. We analyzed interactions between proteins in the cadherin-catenin complex using the yeast two-hybrid system (16, 17) . Fig. 1 shows the growth phenotypes of yeast Y190 transformants as SC-Trp-Leu without 3-AT and SC-Trp-Leu-His with 50 mM 3-AT. All transformants grew on SC-Trp-Leu plates, which select for nutrient markers encoded by the GAL4bd and GAL4ad plasmids. However, growth on SC-Trp-Leu-His with 50 mM 3-AT was restricted to cotransformants expressing E-cadherin-3-catenin, a-catenin-f3-catenin, or p53-simian virus 40 (SV40) large tumor (T)-antigen (positive control). Growth of cotransformants in the latter medium is consistent with expression of corresponding fusion proteins and subsequent reconstitution of GAL4 transcription factor function. Cotransformants expressing a-catenin-E-cadherin did not grow, indicating that fusion proteins containing a-catenin and E-cadherin cytoplasmic domain did not interact. Control experiments were performed with Y190 transformed with individual plasmids that were used in cotransformation growth assays. The resulting transformants did not survive His-and 3-AT selection (data not shown), demonstrating that individual fusion proteins did not activate the his3 reporter gene. Fig. 1 also shows yeast colonies grown on X-Gal indicator plates, which were used to examine expression of the lacZ reporter gene. Cotransformants expressing E-cadherin-f3-catenin, a-catenin-f3-catenin, and p53-SV40 large T antigen formed blue colonies. In contrast, cotransformants expressing a-catenin-E-cadherin did not form blue colonies. Expression of LacZ activity was quantitated by using o-nitrophenyl-13-D- Proteins of apparent molecular masses of 102 kDa, 94 kDa, and 86 kDa were specifically bound by GST-E-cadCD from extracts of MDCK, HCT116, and SW480 cells (Fig. 2 Upper) . The pattern of bound proteins resembles that of the catenins coimmunoprecipitated with E-cadherin when using E-cadherin antibodies (7). In Fig. 2 Lower, the identities of bound proteins as a-catenin, ,3-catenin, and plakoglobin were confirmed by immunoblotting with specific antibodies to each protein. In addition, we found that another armadillo family member, p120, interacted specifically with GST/E-cadCD (Fig.   2 Lower).
In extracts of PC9 cells, which do not contain a-catenin, we found that f3-catenin, plakoglobin, and p120 bound specifically to GST/E-cadCD (Fig. 2 Lower, lanes 10, 12, and 14 ; see also ref. 8) . In some cases (e.g., Fig. 2 Lower, lanes 2, 6, and 12) , proteins with electrophoretic mobilities faster than the respective catenins were detected; these proteins appear to be degradation products even though precautions against proteolysis were taken (see Materials and Methods). These results support a conclusion from our genetic analysis, that Ecadherin cytoplasmic domain binds directly to ,B-catenin in the absence of a-catenin.
There are differences in the relative amounts of a-catenin, ,B-catenin, and plakoglobin bound to GST-E-cadCD from different cell extracts (Fig. 2 Upper) . We sought to determine whether this was due to variations in levels of proteins expressed in different cell lines or differences in the accessibility of catenins to GST-E-cadCD. In immunoblot analysis, HCT116 and SW480 cells expressed similar amounts of a-catenin and plakoglobin, but SW480 cells expressed -3-fold more ,3-catenin than did HCT116 cells (data not shown). To examine whether pools of catenins existed that had different capacities for binding GST-E-cadcD, we fractionated cell lysates by FPLC gel filtration in Superose 6 (Fig. 3) . Fractionation of a SW480 cell extract showed that cadherin eluted in a single sharp peak with an apparent molecular mass of -1,000-2,000 kDa (peak A). a-Catenin (data not shown) and 3-catenin (Fig.  3 Upper) were eluted with a bimodal distribution; -95% of a-catenin (data not shown) and ,B-catenin (Fig. 3 Upper) were eluted in a fraction with an apparent molecular mass of -220 kDa (peak B), and the remainder was eluted in the same fractions that contained cadherin (peak A, Fig. 3 Upper). The elution profile of cadherin from HCT116 cell extracts was similar to that from SW480 cells. However, the elution profiles of a-and /3-catenin were notably different from the profiles in SW480 cells. Eighty percent of both a-catenin (data not shown) and f3-catenin (Fig. 3 Lower) in the HCT1 16 cell extract was eluted in the same peak A fractions that contained E-cadherin, and GST-E-cadCD fusion protein bound to glutathione-agarose beads (lanes 2, 4, and 6). Proteins were separated in SDS/7.5% PAGE gels, and the fluorograms are shown. The arrowheads denote the relative electrophoretic mobilities of a-catenin, ,3-catenin, and plakoglobin (top to bottom). The relative electrophoretic mobilities of molecular weight marker proteins are shown on the right. (Lower) Immunoblots of proteins from cell lysates of SW480 (lanes 1-8) and PC9 cells (lanes [9] [10] [11] [12] [13] [14] bound to GST (lanes 1, 3, 5, 7, 9, 11, and 13) or GST-E-cadCD fusion protein (lanes 2, 4, 6, 8, 10, 12, and 14) . Immunoblots were probed with antibodies specific for a-catenin ( lanes 1 and 2) ; ,B-catenin (lanes 3, 4, 9, and 10); plakoglobin (lanes 5, 6, 11, and 12); and p120 (lanes 7, 8, 13, and 14 (1995) the remainder was eluted in fractions that contained peak B.
The elution profile of plakoglobin was not examined. Analysis of interactions of cadherin and catenins in peak A fractions by coimmunoprecipitation revealed an endogenous complex of these proteins (data not shown). Assuming that the molar ratio of proteins in the cadherin-catenin complex is 1:1:1 E-cadherin/f3-catenin/a-catenin (13, 14, 20) , we would expect a complex of these proteins to have an apparent molecular mass of -350 kDa rather than -1,000-2,000 kDa. However, since cell lysates were fractionated in Superose 6 in buffer containing detergent, we cannot draw conclusions about the absolute molecular mass of complexes separated under these conditions. Nevertheless, the fact that catenins fractionated in a bimodal distribution suggests that catenins exist in at least two different pools.
To test for the interaction of different pools of catenins with exogenous GST-E-cadCD, we performed in vitro binding assays using peak A and B Superose 6 column fractions. From HCT116 (Fig. 3 Lower) and SW480 (data not shown) cells, only P3-catenin that eluted in peak B fractions bound GST-E-cadCD.
This result supports the general conclusion that E-cadCD interacts directly with f3-catenin. In contrast, ,3-catenin from fractions composing peak A did not bind GST-E-cadCD. Since the high molecular weight pool of ,B-catenin is bound to endogenous E-cadherin, these results indicate that ,B-catenin bound to one E-cadherin molecule cannot bind to a second cadherin. In contrast, /3-catenin in peak B fractions is accessible to exogenous E-cadherin. This implies that this pool of /3-catenin is not excluded from the endogenous E-cadherincatenin complex because it is not competent to bind to E-cadherin but rather that it constitutes a separate catenin pool. Partitioning of /3-catenin into different protein pools may be important for the regulation of cadherin-catenin complex assembly (13, 14) and the binding of /3-catenin to other proteins such as APC (adenomatous polyposis coli) and EGF (epidermal growth factor) receptor (18, 19, 21) .
To investigate interactions between a-catenin and armadillo family members in cell extracts, we expressed histidine-tagged a-catenin in E. coli and tested its binding to proteins in detergent extracts of MDCK cells. 3-Catenin and plakoglobin bound to histidine-tagged a-catenin (Fig. 4) . Significantly, neither E-cadherin nor p120 were detectably bound to a-catenin fusion protein. This finding confirms biochemically that E-cadherin and a-catenin do not interact directly and that ,B-catenin binds to a-catenin.
These binding assays revealed an unexpected difference between f3-catenin, plakoglobin, and p120, all of which are structurally related (22) . p120 bound to GST-E-cadCD (Fig. 2 Lower) but not to histidine-tagged a-catenin (Fig. 4) . However, In vitro protein binding assay using histidine-tagged a-catenin and MDCK cell lysate. MDCK cell lysates were incubated with histidine-tagged a-catenin or E. coli lysate bound to nickel-Sepharose. Proteins were separated in SDS/7.5% PAGE gels and processed for immunoblotting with specific antibodies: ,3-catenin (lanes 1-3) , plakoglobin (lanes 4-6), p120 (lanes [7] [8] [9] [10] , and E-cadherin (lanes [11] [12] [13] [14] .
Lanes: 1, 6, 9, and 13, proteins from an E. coli lysate bound to nickel-Sepharose and histidine-tagged a-catenin; 2 other members of the armadillo family, /3-catenin and plakoglobin, bound both GST-E-cadCD and histidine-tagged a-catenin (Fig. 4) (Fig. 5) . We also examined whether a-catenin formed homodimers, as suggested by its sequence homology to vinculin (23) . We found that neither the his3 nor lacZ reporter genes were activated by cotransformation of plasmids containing a-catenin fused to both the GAL4bd and GAL4ad vectors (LacZ activity was 0.49 + 0.14 nmol/min/mg of protein extract from three independent clones) (Fig. 5 ).
These results reveal that binding sites for ,B-catenin are located in the cytoplasmic domain of E-cadherin and the amino-terminal domain of a-catenin, respectively. Analysis of the amino acid sequences of these two ,3-catenin-binding domains deduced from cDNAs reveals little or no homology. Although we have not determined the kinetics of protein binding, it is noteworthy that a-catenin can be removed from the E-cadherin-catenin complex with octylglucoside (7) or high salt (13) , whereas ,B-catenin cannot. This suggests differences in the molecular interaction between binding sites for 3-catenin on E-cadherin and a-catenin, respectively.
Defining the order of protein-protein interactions in the E-cadherin-catenin complex is important for understanding the structure, function, and regulation of the assembly of this complex. To determine protein-protein interactions in the cadherin-catenin complex, previous studies have used specific antibodies to deplete one component from the cadherincatenin complex and study interactions between the remaining molecules (13, 14) . Alternatively, cadherin-catenin interactions in cell lines that lack one component of the complex, such as the a-catenin-deficient PC9 cells, have been examined (8) . Nevertheless, a caveat to those studies is that other proteins may affect cadherin-catenin interactions. The results presented in this study show a synergistic approach to this problem using a combination of a yeast genetic assay and a biochemical assay. Our data reveal that the trimolecular complex has the following binding order of proteins: E-cadherin ,B 3-catenin * a-catenin. A small region of the cytoplasmic domain of E-cadherin binds to f-catenin, and 13-catenin binds to the amino terminus of a-catenin, while E-cadherin does not bind directly to a-catenin. Since evidence shows that ,B-catenin is at the convergence of several signal transduction pathways involving Src tyrosine kinase (24) (25) (26) and extracellular signaling molecules (epidermal and hepatocyte growth factors and Wnt-1) (19, (27) (28) (29) , the finding that 13-catenin is the linker protein between E-cadherin and a-catenin strengthens the hypothesis that,B-catenin plays a pivotal role in regulating the structural organization and function of the cadherin-catenin complex.
